Polyphenols: key issues involved in chemoprevention of prostate cancer
- PMID: 22690272
- PMCID: PMC3368543
- DOI: 10.1155/2012/632959
Polyphenols: key issues involved in chemoprevention of prostate cancer
Abstract
Prostate cancer is is the most common solid neoplasm and it is now recognized as one of the most important medical problems facing the male population. Due to its long latency and its identifiable preneoplastic lesions, prostate cancer is an ideal target tumor for chemoprevention. Different compounds are available and certainly polyphenols represent those with efficacy against prostate cancer. This review take a look at activity and properties of major polyphenolic substances, such as epigallocatechin-3-gallate, curcumin, resveratrol and the flavonoids quercetin and genistein. Although the current studies are limited, mechanisms of action of polyphenols added with the lack of side effects show a a start for future strategies in prostate chemoprevention.
Figures
References
-
- Rittmaster RS. Chemoprevention of prostate cancer. Acta Oncologica. 2011;50(supplement 1):127–136. - PubMed
-
- Ślusarz A, Shenouda NS, Sakla MS, et al. Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Research. 2010;70(8):3382–3390. - PubMed
-
- Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP, Gescher AJ. Dietary polyphenolic phytochemicals—promising cancer chemopreventive agents in humans? A review of their clinical properties. International Journal of Cancer. 2007;120(3):451–458. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
